Alamar Biosciences (ALMR) vs Neogen (NEOG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Neogen is the larger company by market cap ($2.55 billion vs $1.80 billion), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | NEOG |
|---|---|---|
| Share price | $25.91 | $11.71 |
| Market cap | $1.80B | $2.55B |
| 1-day change | -6.70% | +0.26% |
| YTD return | — | +67.53% |
| 1-year return | — | +101.20% |
| 5-year return | — | -71.47% |
| Forward P/E | — | 30.82 |
| EPS (TTM) | $-1.20 | $-0.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $870.40M |
| Revenue growth (YoY) | — | -2.72% |
| Net income (latest FY) | — | $-7.90M |
| Gross margin | — | 46.93% |
| Operating margin | — | -2.48% |
| Net margin | — | -0.91% |
| 52-week high | $39.61 | $14.26 |
| 52-week low | $18.85 | $5.37 |
| Distance from 52-week high | -34.59% | -17.88% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +36.63% | +19.56% |
| Average volume | 411.15K | 3.02M |
| Shares outstanding | 69.39M | 218.11M |
| Employees | 286 | 2,636 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Alamar Biosciences in Industrials and Neogen in Health Care.
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About Neogen
NEOG stock →Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 2,636 employees
ALMR vs NEOG FAQ
Which is bigger, Alamar Biosciences or Neogen?
Neogen (NEOG) is larger, with a market capitalization of $2.55B compared with $1.80B for Alamar Biosciences (ALMR).
Are Alamar Biosciences and Neogen in the same industry?
No. Alamar Biosciences is in the Industrials sector, while Neogen is in Health Care.